Yamo Pharmaceuticals

900 Third Avenue, 19th Floor
New York
New York
10022
United States

Show jobs for this employer

About Yamo Pharmaceuticals

Yamo Pharmaceuticals is a clinical stage pharmaceutical company founded in 2015 to develop L1-79, a novel therapy with the potential to improve the core symptoms of Autism spectrum disorder. L1-79 is a novel, well-tolerated mechanism that targets the central nervous system and metabolic symptoms of autism. More information may be found at www.yamopharma.com.

4 articles with Yamo Pharmaceuticals